On the other hand, high expression of IGF-1R in tumor samples correlates with unfavorable prognosis in BLCA (HR = 1.01, p = 0.045), LIHC (HR = 1.06, p = 0.013), and LUAD (HR = 1.01, p = 0.024); whereas, high expression of IGF-1R correlates with favorable prognosis in KIRC (HR = 0.97, p < 0.0001) and LAML (HR = 0.98, p = 0.0011) (Figures 3A–E). Here, IGF1R is linked to bladder transitional cell carcinoma.